WuXi Biologics ISIN: KYG970081173 Forum: Aktien User: Summer.76

Anzeige
Smartbroker
Der Broker von Deutschlands größter Finanzcommunity
8,90 USD
+2,18 %+0,19
11. Aug, 23:19:58 Uhr, Nasdaq OTC
Kommentare 594
Summer.76
Summer.76, Mittwoch 6:17
0
"HSI Deepens Loss to Over 350 Pts; CN Consumers, Drugs In Sell-off; Anta, BYD, Techtronic Ind, WuXi Bio Sink Over 4-6% AASTOCKS Financial News - Latest News" http://www.aastocks.com/en/stocks/news/aafn-con/now.1203517/latest-news
Summer.76
Summer.76, 5. Aug 9:32
0
http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1202446/company-news/HK6
Summer.76
Summer.76, 4. Aug 6:09
0
WuXi Biologics (02269) rose over 4%, reached strategic cooperation with AstraZeneca for the localized production of new crown prevention and neutralizing antibody Enshide https://finance.sina.cn/hkstock/sckxjfx/2022-08-04/detail-imizmscv4789918.d.html?from=wap
Summer.76
Summer.76, 1. Aug 15:54
0
WuXi Biologics Steps into the Harvest Period, Actively Strengthens the Global... https://www.donews.com/article/detail/6337/44980.html
Summer.76
Summer.76, 27. Jul 10:29
0
Buoyed By Bumper Profits, WuXi Biologics Seeks To Bolster Global Supply Chain https://seekingalpha.com/article/4526161-buoyed-by-bumper-profits-wuxi-biologics-seeks-to-bolster-global-supply-chain Summary • Drugs services provider WuXi Biologics has issued a positive earnings alert for the first half of the year, predicting revenue would rise by up to 63% and net profit would jump as much as 37%. • The provider of outsourced pharmaceutical services has delivered on bullish market hopes of rapid earnings growth. • It plans to invest around $1.44 billion in a new research and production hub in Singapore to strengthen its global supply network. ...
Summer.76
Summer.76, 26. Jul 8:10
0
https://finance.sina.cn/hkstock/ggyw/2022-07-26/detail-imizirav5455315.d.html?from=wap
Summer.76
Summer.76, 25. Jul 10:08
0
Morgan Stanley: Maintain "Overweight" rating on WuXi Biologics (02269) with a target price of HK$119.8 https://finance.sina.cn/hkstock/ggpj/2022-07-25/detail-imizmscv3446393.d.html?from=wap
Summer.76
Summer.76, 20. Jul 5:15
0
"CICC: Maintain WuXi Biologics (02269) "Outperform the Industry" Rating Target Price Raised to HK$96.8 Provider Zhitong Finance" https://m.hk.investing.com/news/stock-market-news/article-242935
Summer.76
Summer.76, 20. Jul 5:11
0
"Biologics firm sees good growth | The Standard" https://www.thestandard.com.hk/section-news/section/2/243786/Biologics-firm-sees-good-growth
Summer.76
Summer.76, 19. Jul 14:11
0
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore https://www.prnewswire.co.uk/news-releases/wuxi-biologics-plans-to-build-a-comprehensive-crdmo-center-in-singapore-828331481.html • This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore, including a research and development service center and large-scale drug substance and drug product manufacturing facilities for biologics • The investment strengthens WuXi Biologics' global research, development and manufacturing network with more robust nodes to meet the growing demand from clients worldwide for end-to-end services, and continues to enable its Global Dual Sourcing strategy ...
Summer.76
Summer.76, 19. Jul 6:17
0
""Earnings Prediction" WuXi Biologics (02269 HK) Expects 1H10 Profit to Grow 36% to 38% YoY" http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1198194/popular-news/HK6
Summer.76
Summer.76, 19. Jul 6:13
0
https://finance.sina.cn/hkstock/sckxjfx/2022-07-19/detail-imizmscv2440001.d.html?from=wap
Summer.76
Summer.76, 12. Jul 16:31
0
WuXi Vaccines Received First GMP Certificate of QC Potency Lab from Ireland Health Products Regulatory Authority https://enmobile.prnasia.com/releases/global/wuxi-vaccines-received-first-gmp-certificate-of-qc-potency-lab-from-ireland-health-products-regulatory-authority-368058.shtml
Summer.76
Summer.76, 11. Jul 18:15
0
http://www.aastocks.com/tc/stocks/news/aafn-con/.hk.220711_094632/latest-news
Summer.76
Summer.76, 11. Jul 5:45
0
https://finance.sina.cn/hkstock/ggpj/2022-07-11/detail-imizirav2833183.d.html?from=wap
Meistdiskutiert
Kommentare
1 NEL ASA Hauptdiskussion +0,63 %
2 FEMALE HEALTH Hauptdiskussion +36,02 %
3 VOLITIONRX LTD DL-,001 Hauptdiskussion -0,50 %
4 AMC ENTERTAINMENT Hauptdiskussion +7,07 %
5 MEYER BURGER Hauptdiskussion +5,10 %
6 BioNTech Hauptdiskussion -1,45 %
7 EVRAZ Hauptdiskussion -86,79 %
8 Mullen Automotive Hauptdiskussion +1,10 %
9 SORRENTO THERAPEUTICS Hauptdiskussion -7,12 %
10 Vulcan Energy Resources Hauptdiskussion +7,36 %
Alle Diskussionen
Aktien
Kommentare
1 NEL ASA Hauptdiskussion +0,63 %
2 FEMALE HEALTH Hauptdiskussion +36,02 %
3 VOLITIONRX LTD DL-,001 Hauptdiskussion -0,50 %
4 MS BioNTech -1,45 %
5 AMC ENTERTAINMENT Hauptdiskussion +7,07 %
6 MEYER BURGER Hauptdiskussion +5,10 %
7 BioNTech Hauptdiskussion -1,45 %
8 EVRAZ Hauptdiskussion -86,79 %
9 Mullen Automotive Hauptdiskussion +1,10 %
10 SORRENTO THERAPEUTICS Hauptdiskussion -7,12 %
Alle Diskussionen
Werbung
Ihre kurzfristige Erwartung an
steht am  bei
Veränderung:  
mgl. Rendite mit
Hebel (Omega)
Zum Produkt